Search by Drug Name or NDC
NDC 00031-8702-13 Childrens Robitussin Cough and Chest Congestion DM 20; 200 mg/20mL; mg/20mL Details
Childrens Robitussin Cough and Chest Congestion DM 20; 200 mg/20mL; mg/20mL
Childrens Robitussin Cough and Chest Congestion DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 00031-8702-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00031-8702-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 00031-8702 |
---|---|
Product ID | 0031-8702_6dbc0a50-8ae8-4587-8e75-9e72bf47e00c |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Childrens Robitussin Cough and Chest Congestion DM |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dextromethorphan hydrobromide and guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 20; 200 |
Active Ingredient Units | mg/20mL; mg/20mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00031-8702-13 (00031870213)
NDC Package Code | 0031-8702-13 |
---|---|
Billing NDC | 00031870213 |
Package | 1 BOTTLE in 1 CARTON (0031-8702-13) / 118 mL in 1 BOTTLE |
Marketing Start Date | 2020-05-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |